Note Conversion Agreement News Today

KANSAS CITY, Kan., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING) (Cingulate), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build

Akanda Corp. Unaudited Condensed Interim Consolidated Statements of Financial Position As at ...

Insider warrant exercise and new credit facility improve balance sheet ...

Conversion of significant debt to equity and extension of short-term note delivers significantly improved debt position for the company as it looks forward to the year ahead ...